SCHEMBL15834849

SCHEMBL15834849

CNNNNNC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18387925 1.00 KDM4E (0.40)
SCHEMBL12064571 1.00
SCHEMBL15251569 1.00 KDM4E (0.40)
SCHEMBL15672771 1.00 KDM4E (0.40)
SCHEMBL14752949 1.00 KDM4E (0.40)
SCHEMBL16800551 1.00 KDM4E (0.40)
SCHEMBL17830192 1.00 KDM4E (0.40)
SCHEMBL17951915 1.00 KDM4E (0.40)
SCHEMBL16949457 1.00
SCHEMBL13528155 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3738623-B1 DEGRADABLE VASCULAR STENT CAPABLE OF AVOIDING LATE RESTENOSIS SHANDONG HUAAN BIOTECHNOLOGY CO LTD (CN) 2023-08-16 EP disclosed
US-20150376121-A1 ANTIOXIDANT INFLAMMATION MODULATORS: OLEANOLIC ACID DERIVATIVES WITH AMINO AND OTHER MODIFICATIONS AT C-17 REATA PHARMACEUTICALS, INC. (US) 2015-12-31 US disclosed
US-9173600-B2 Systems and methods for the identification of compounds in medical fluids using admittance spectroscopy S.E.A. MEDICAL SYSTEMS, INC. (US) 2015-11-03 US disclosed
US-20140179978-A1 Neutron Source for Neutron Capture Therapy ADELPHI TECHNOLOGY, INC. (US) 2014-06-26 US disclosed